[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"high-altitude-pulmonary-edema\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:high-altitude-pulmonary-edema":57},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,42],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100634191","high-flow-nasal-cannula-oxygen-therapy-versus-conventional-oxygen-therapy-in-high-altitude-pulmonary-edema-100634191",false,"NCT07536477","High-flow Nasal Cannula Oxygen Therapy Versus Conventional Oxygen Therapy in High-altitude Pulmonary Edema","High-flow Nasal Cannula Oxygen Therapy Versus Conventional Oxygen Therapy in Patients With High-altitude Pulmonary Edema: A Prospective Randomized Controlled Study","Inclusion Criteria:\n\n1. Aged 18 years or older;\n2. Onset of symptoms related to HAPE (including dyspnea at rest, cough, or exercise intolerance) within 7 days of ascending to high altitude (≥2500m);\n3. Diagnosis of HAPE according to the STAR data reporting guidelines, requiring at least two symptoms (dyspnea at rest, cough, weakness\u002Fdecreased exercise performance, or chest tightness\u002Fcongestion) and two clinical signs (rales or wheezing in at least one lung field, central cyanosis, tachypnea, or tachycardia);\n4. Radiographic evidence of pulmonary edema on chest X-ray or CT;\n5. Refusal or inability to undergo immediate descent at the time of presentation;\n6. Capability and willingness to provide written informed consent.\n\nExclusion criteria:\n\n1. Known or clinically confirmed pregnancy;\n2. Requirement for emergency intubation (as assessed by the treating clinician) due to cardiac\u002Frespiratory arrest, hemodynamic instability, airway compromise, severe hypoxia, or impaired consciousness, etc;\n3. Pulmonary edema or hypoxemia resulting from other medical conditions (e.g., cardiogenic pulmonary edema, sepsis, chronic obstructive pulmonary disease (COPD), pneumothorax, massive pleural effusion, chest trauma, etc.);\n4. Glasgow Coma Scale (GCS) score ≤ 12;\n5. PaCO₂ \\> 55 mmHg;\n6. Presence of high-altitude cerebral edema;\n7. Receipt of any respiratory support therapy (other than conventional oxygen therapy) prior to admission;\n8. Presence of any contraindication to conventional or nasal oxygen therapy;\n9. Presence of severe medical conditions or abnormal clinical laboratory findings that, in the investigator's judgment, may pose a risk to the patient's safety or interfere with the study's execution and participant completion;\n10. Current participation in other clinical trials;\n11. Refusal to sign the informed consent form.","ALL","18 Years",{"count":19,"type":20},208,"ESTIMATED","INTERVENTIONAL",[23],"NA","This study aims to evaluate whether High-flow Nasal Cannula Oxygen Therapy (HFNC) provides superior respiratory support compared to Conventional Oxygen Therapy (COT) in patients with High-Altitude Pulmonary Edema (HAPE).",[26],"High-altitude Pulmonary Edema",[28],"HAPE","RECRUITING","2026-08-09",{"date":32,"type":33},"2026-08-11","ACTUAL",{"date":35,"type":33},"2026-04-25",{"date":37,"type":20},"2029-04-22",{"name":39,"class":40},"Third Military Medical University","OTHER",1,{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":4,"eligibilityCriteria":48,"healthyVolunteers":49,"sex":16,"minAge":17,"maxAge":50,"enrollmentInfo":51,"targetDuration":4,"studyType":53,"phases":4,"briefSummary":54,"conditions":55,"keywords":58,"overallStatus":68,"whyStopped":4,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":4},"100650069","the-cardiovascular-effects-of-patent-foramen-ovale-in-hypoxia-100650069","NCT07742540","The Cardiovascular Effects of Patent Foramen Ovale in Hypoxia","The Role of Patent Foramen Ovale on Cardiac Hemodynamics and Exercise Cardiac Reserve in HAPE-susceptible Individuals","Inclusion Criteria:\n\n* Males and females age \\> 18 but \\\u003C 60 years of age at the time of signing the informed consent.\n* Medically documented episode of noncardiogenic pulmonary edema occurring after exposure to hypoxia at high altitude.\n* No other associated congenital cardiac or vascular abnormalities.\n* Physically active, and able to perform endurance exercise.\n\nExclusion Criteria:\n\n* Do not otherwise meet the inclusion criteria.\n* Cardiac- or pulmonary-related medications.\n* Known history of anemia, iron deficiency, iron supplementation (oral or intravenous) in the preceding 60 days.\n* Systemic anticoagulation or aspirin use that cannot be temporarily held for the study.\n* Non-cardiopulmonary disorders that adversely influence exercise ability (e.g. arthritis or peripheral vascular disease).\n* Engaging in vigorous physical activity \\[≥1 hour at ≥6 mets\\] at ≥8,000 ft for \\>2 days per week over the preceding 4 weeks, and residing at ≥8,000 ft for 3 or more consecutive nights in the preceding 30 days.\n* History of any recent illnesses (e.g. viral respiratory infections) within 4 weeks of testing.\n* Women who are pregnant (urine pregnancy test given to all women of childbearing age at the time of testing).\n* Other conditions that would limit the patient's ability to complete the study procedures.",true,"60 Years",{"count":52,"type":20},50,"OBSERVATIONAL","Before birth, the foramen ovale is a normal opening in the heart that allows blood to flow from the mother to the baby. After birth, this opening usually closes. However, in up to 38% of the population it does not fully close and is then called a patent foramen ovale (PFO). Having a PFO allows venous (blue) blood to mix with arterial (red) blood in the heart, which can lower blood oxygen levels. The mixing of blood has been suggested to be greater during exercise and with exposure to high-altitude. Also, people with a PFO may be a greater risk for severe altitude sickness, specifically involving the collection of fluid in the lungs which makes breathing very difficult - this is called high-altitude pulmonary edema (HAPE).\n\nNo study has directly measured the pressure difference across the heart which is required for the mixing of blood during exercise or at high-altitude. The present study will directly measure the pressure difference across the heart, as well as blood flow through the PFO during rest and exercise in simulated high altitude in adults with and without a PFO and a previous history of severe altitude sickness. The study will test the hypothesis that elevations in pulmonary artery pressure during exposure to hypoxia will not elicit a pressure gradient, and thus blood flow, across the PFO neither at rest nor during exercise.",[56,57],"Patent Foramen Ovale (PFO)","High Altitude Pulmonary Edema",[59,60,61,62,63,64,65,66,67],"hypoxia","altitude","heart","high altitude pulmonary edema","patent foramen ovale","exercise","pulmonary artery pressure","intracardiac pressures","right-to-left shunt","NOT_YET_RECRUITING","2026-07-28",{"date":71,"type":33},"2026-08-03",{"date":73,"type":20},"2026-09-15",{"date":75,"type":20},"2028-09-15",{"name":77,"class":40},"University of Texas Southwestern Medical Center"]